{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:21:25Z","timestamp":1794010885243,"version":"4.8.0"},"reference-count":27,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,3,28]],"date-time":"2006-03-28T00:00:00Z","timestamp":1143504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hemodialysis International"],"published-print":{"date-parts":[[2006,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Little is known about proton pump inhibitor (PPI) or H<jats:sub>2<\/jats:sub> receptor antagonist (HA) prescription patterns or regarding use of predictors in hemodialysis patients. Proton pump inhibitor and HA prescribing patterns were investigated in 8628 hemodialysis patients from seven countries enrolled in the prospective, observational Dialysis Outcomes and Practice Patterns Study. Logistic regression examined predictors associated with PPI and HA use, adjusting for age, sex, country, time with end\u2010stage renal disease, medications, 14 comorbid conditions, and the association between the number of comorbid conditions and the prescription of gastrointestinal (GI) medications. In a cross\u2010section from February 1, 2000, 3.4% to 36.9% of patients received an HA and 0.8% to 26.9% took a PPI, depending upon the country. From 1996 to 2001, the prescription of HAs declined while PPI use increased. Facility use of HAs and PPIs ranged from 0% to 94% of patients. H<jats:sub>2<\/jats:sub> receptor antagonist or PPI use was significantly and independently associated with age, narcotic use, corticosteroids, acetaminophen, nonsteroidal anti\u2010inflammatory drugs, tricyclic antidepressants, selective serotonin reuptake inhibitors, coronary artery disease history, cardiovascular diseases other than hypertension or congestive heart failure, peripheral vascular disease, pulmonary disease, and GI bleed. Proton pump inhibitors or HAs were more likely to be prescribed in Italy, Spain, and the United Kingdom than in the United States. The odds of PPI prescription increased if serum phosphorus &lt;5.5\u2003mEq\/L or serum albumin &lt;3.5\u2003g\/dL. Prescription of GI medications was associated with many comorbidities and use of several medications. Extreme variability of prescription patterns suggests that there is no standard approach in treatment practices.<\/jats:p>","DOI":"10.1111\/j.1542-4758.2006.00092.x","type":"journal-article","created":{"date-parts":[[2006,3,28]],"date-time":"2006-03-28T08:53:55Z","timestamp":1143536035000},"page":"180-188","source":"Crossref","is-referenced-by-count":19,"title":["Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: The Dialysis Outcomes and Practice Patterns Study (DOPPS)"],"prefix":"10.1111","volume":"10","author":[{"given":"George r.","family":"BAILIE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy a.","family":"MASON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey j.","family":"ELDER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio e.","family":"ANDREUCCI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger n.","family":"GREENWOOD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"AKIBA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"SAITO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer l.","family":"BRAGG\u2010GRESHAM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda w.","family":"GILLESPIE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric w.","family":"YOUNG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,3,28]]},"reference":[{"issue":"3","key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"S295","DOI":"10.1177\/089686080102103S52","article-title":"Gastroesophageal reflux and hyperacidity in chronic renal failure","volume":"21","author":"Fallone CA","year":"2001","journal-title":"Perit Dial Int"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00225.x"},{"key":"e_1_2_6_4_2","first-page":"1352","article-title":"Gastroesophageal reflux disease in chronic renal failure patients with upper GI symptoms","volume":"97","author":"Cekin AH","year":"2002","journal-title":"Multivariate analysis of pathogenetic factors"},{"issue":"1","key":"e_1_2_6_5_2","first-page":"S11","article-title":"Gastrointestinal disease and the kidney","volume":"14","author":"Francisco AL.","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/18.3.570"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.86"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199427050-00006"},{"key":"e_1_2_6_9_2","first-page":"253","article-title":"Central nervous system reactions associated with famotidine","volume":"27","author":"Odeh M","year":"1998","journal-title":"Report of five cases"},{"key":"e_1_2_6_10_2","first-page":"855","article-title":"Antacids revisited","volume":"57","author":"Maton PN","year":"1999","journal-title":"A review of their clinical pharmacology and recommended therapeutic use"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200124010-00004"},{"key":"e_1_2_6_12_2","volume-title":"Annual Data Report","author":"United States Renal Data System (USRDS).","year":"1998"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/57.9.902"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2003.50048"},{"issue":"74","key":"e_1_2_6_15_2","first-page":"S74","article-title":"The Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"57","author":"Young EW","year":"2000","journal-title":"An international hemodialysis study"},{"key":"e_1_2_6_16_2","first-page":"157","article-title":"The dialysis outcomes and practice patterns study (DOPPS)","volume":"14","author":"Goodkin DA","year":"2001","journal-title":"How can we improve the care of hemodialysis patients?"},{"key":"e_1_2_6_17_2","first-page":"1452","volume-title":"SAS\/STAT User's Guide, Version 8","author":"SAS Institute.","year":"1999"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.03.077"},{"key":"e_1_2_6_19_2","first-page":"1647","article-title":"Epidemiology of gastroesophageal reflux disease","volume":"10","author":"Wang JH","year":"2004","journal-title":"A general population-based study in Xi'an of northwest China"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.04169.x"},{"key":"e_1_2_6_21_2","first-page":"21","article-title":"Diagnosis and treatment of gastroesophageal reflux disease in Ohio medicaid patients","volume":"13","author":"Cooper GS","year":"2004","journal-title":"Practice patterns and temporal trends"},{"key":"e_1_2_6_22_2","first-page":"2419","article-title":"Analgesic prescription patterns among hemodialysis patients in the DOPPS","volume":"65","author":"Bailie GR","year":"2004","journal-title":"Potential for underprescription"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.09.025"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41217.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00684.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11938-005-0009-9"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1155\/2005\/836030"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.MLG.0000165464.75164.E5"}],"container-title":["Hemodialysis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1542-4758.2006.00092.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1542-4758.2006.00092.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T09:15:54Z","timestamp":1697015754000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1542-4758.2006.00092.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,28]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["10.1111\/j.1542-4758.2006.00092.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1542-4758.2006.00092.x","archive":["Portico"],"relation":{},"ISSN":["1492-7535","1542-4758"],"issn-type":[{"value":"1492-7535","type":"print"},{"value":"1542-4758","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,28]]}}}